Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer.
11/10/2019
/
Publications
/
Reirradiation
This retrospective study analyzing 16 patients with locally recurrent breast cancer who underwent re-irradiation to the chest wall with PBT to the median dose...
A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors.
11/07/2019
/
Publications
/
Toxicity
Reirradiation
Sixty-nine patients with sinonasal tumors underwent curative intent PBT including 42 patients received de novo irradiation and 27 received reirradiation. With...
Proton Beam Therapy for Locally Recurrent Parotid Gland Cancer.
07/07/2016
/
Publications
This study from Japan evaluated outcomes of PBT for locally recurrent parotid gland cancer. Ten patients were treated to 70.2 Gy equivalents in 32 fractions...
High-dose conformal proton therapy for clinical perineural invasion in cutaneous head and neck cancer.
11/12/2019
/
Publications
/
Hypofractionation
Perineural invasion (PNI) is an uncommon (<5%) which refers to tumor cell invasion extensive enough to cause clinically detectable deficits of the involved...
Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.
07/07/2016
/
Publications
/
Survival
Based on the national cancer database, there were total of 175,088 patients with HNSCC receiving either photon or proton RT. This analysis pointed out that...
Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
11/11/2019
/
Publications
/
Toxicity
Hepatocellular carcinoma (HCC) with inferior vena cava tumor thrombus (IVCTT) is rare and regarded as an advanced disease stage with a poor prognosis. This...
Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
11/11/2019
/
Publications
/
Toxicity
Survival
Chemotherapy
This study from Taiwan retrospectively examined 30 patients with unresectable CC who were treated with PBT to a total dose of 72.6 GyRBE. The 1-year local...
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
11/12/2019
/
Publications
/
Hypofractionation
Survival
This study by MGH retrospectively analyzed 66 patients with unresectable intrahepatic cholangiocarcinoma (ICC) who were treated with hypofractionated proton (32...
Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer.
11/11/2019
/
Publications
/
Chemotherapy
Survival
Published in JAMA, the paper by the UPenn group accessed PBT side effects in the concurrent chemoradiotherapy for locally advanced cancer setting. 1483 adult...
Hadrontherapy for cancer. An overview of HTA reports and ongoing studies
12/12/2019
/
Publications
/
Secondary cancer
Hadron therapy often refers to proton therapy (PBT) and carbon ion therapy (CIRT) are not new technologies, but have been subject to assessment by several...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.